7
Views
8
CrossRef citations to date
0
Altmetric
Original Papers

Evaluation of the Sentinel Node Biopsy in Colorectal Carcinoma Including the Results of Immunohistochemical Examinations

, , , , &
Pages 45-48 | Published online: 11 Mar 2016
 

Abstract

Aim: To evaluate the method and results of sentinel node biopsy including immunohistochemical examinations in resectable colorectal cancer.

Material and methods: From April 2004 to April 2005, sentinel node biopsy was carried out with the dye method in 27 patients operated on for colorectal cancer. The standard examination of sentinel nodes consisted in the evaluation of individual H&E-dyed specimens from bisection of the node. The negative sentinel nodes were examined with the use of immunohistochemistry against cytokeratins AE1/AE3.

Findings: The sentinel node was identified in 25 patients (92.6%). In a routine histopathological examination it included metastases in 3 cases. The sentinel node was clean in one patient whereas other regional nodes resected “en bloc” with the tumour included metastases. The sensitivity of the method was 75%, and the number of falsely negative results was 25%. Metastases (micrometastases) in the sentinel node were found in 2 other patients (8%) in the immunohisto-chemical examination. This examination did not change the results of the analysis in the patient with positive non-sentinel nodes and with the negative sentinel node in H&E dyeing. Nevertheless, the sensitivity of the method rose to 83.3% and the number of falsely negative results dropped to 16.7%. Conclusions :

1. The sentinel node biopsy using the dye method is a safe and relatively easy technique showing a high success rate (92.6%).

2. Low sensitivity of the method, as reflected in the literature, may result from lack of extended histopathological examinations performed on the sentinel node (e.g. immunohistochemistry).

3. Further research is necessary to determine the role and importance of the sentinel node biopsy in colorectal cancer.

Additional information

Notes on contributors

D. Murawa

D. Murawa 1st Clinic of Surgical Oncology, Great Poland Cancer Center (Wielkopolskie Centrum Onkologii) ul. Garbary 15 PL-61-866 Poznan, Poland Tel.: +48 505 488585 or +48 61 8540600 Fax: +48 61 8540601 E-mail: [email protected]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.